Solveig Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 14-12-2024
- Paid Up Capital ₹ 1.50 M
as on 14-12-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.05 M
as on 14-12-2024
- Revenue -35.48%
(FY 2021)
- Profit -171.49%
(FY 2021)
- Ebitda -142.42%
(FY 2021)
- Net Worth -49.05%
(FY 2021)
- Total Assets 4.83%
(FY 2021)
About Solveig Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.50 M.
The company has closed loans amounting to ₹1.05 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sunanda Wagh, Shailesh Dagwar, and Vyankati Wagh serve as directors at the Company.
- CIN/LLPIN
U74900MH2016PTC273198
- Company No.
273198
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Wardha, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Solveig Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vyankati Wagh  | Managing Director | 29-Sep-2018 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shailesh Dagwar | Whole-Time Director | 12-Dec-2021 | Current |
| Sunanda Wagh | Director | 08-Jun-2022 | Current |
Financial Performance of Solveig Lifesciences.
Solveig Lifesciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 35.48% decrease. The company also saw a substantial fall in profitability, with a 171.49% decrease in profit. The company's net worth observed a substantial decline by a decrease of 49.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Solveig Lifesciences?
In 2021, Solveig Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Solvey Formulations Private LimitedActive 1 year 1 monthSunanda Wagh and Vyankati Wagh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Aug 2020 | ₹0.35 M | Satisfied |
Others Creation Date: 19 Jan 2019 | ₹0.70 M | Satisfied |
How Many Employees Work at Solveig Lifesciences?
Unlock and access historical data on people associated with Solveig Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Solveig Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solveig Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
